Cargando…
Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients
Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693372/ https://www.ncbi.nlm.nih.gov/pubmed/33147819 http://dx.doi.org/10.3390/antibiotics9110771 |
_version_ | 1783614728877113344 |
---|---|
author | Joao, Ines Bujdáková, Helena Jordao, Luisa |
author_facet | Joao, Ines Bujdáková, Helena Jordao, Luisa |
author_sort | Joao, Ines |
collection | PubMed |
description | Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fungal spp. (mainly, Aspergillus fumigatus, Histoplasma capsulatum and Cryptococcus neoformans) is very challenging and is associated with poor patient prognosis. The most frequent clinical symptoms for coinfection and infection by single agents (fungi or NTM) are similar. For this reason, the accurate identification of the aetiological agent(s) is crucial to select the best treatment approach. Despite the significance of this topic it has not been sufficiently addressed in the literature. This review aims at summarizing case reports and studies on NTM and fungi coinfection during the last 20 years. In addition, it briefly characterizes OPIs and coinfection, describes key features of opportunistic pathogens (e.g., NTM and fungi) and human host predisposing conditions to OPIs onset and outcome. The review could interest a wide spectrum of audiences, including medical doctors and scientists, to improve awareness of these infections, leading to early identification in clinical settings and increasing research in the field. Improved diagnosis and availability of therapeutic options might contribute to improve the prognosis of patients’ survival. |
format | Online Article Text |
id | pubmed-7693372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76933722020-11-28 Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients Joao, Ines Bujdáková, Helena Jordao, Luisa Antibiotics (Basel) Review Nontuberculous mycobacteria (NTM) and many fungal species (spp.) are commonly associated with opportunistic infections (OPIs) in immunocompromised individuals. Moreover, occurrence of concomitant infection by NTM (mainly spp. of Mycobacterium avium complex and Mycobacterium abscessus complex) and fungal spp. (mainly, Aspergillus fumigatus, Histoplasma capsulatum and Cryptococcus neoformans) is very challenging and is associated with poor patient prognosis. The most frequent clinical symptoms for coinfection and infection by single agents (fungi or NTM) are similar. For this reason, the accurate identification of the aetiological agent(s) is crucial to select the best treatment approach. Despite the significance of this topic it has not been sufficiently addressed in the literature. This review aims at summarizing case reports and studies on NTM and fungi coinfection during the last 20 years. In addition, it briefly characterizes OPIs and coinfection, describes key features of opportunistic pathogens (e.g., NTM and fungi) and human host predisposing conditions to OPIs onset and outcome. The review could interest a wide spectrum of audiences, including medical doctors and scientists, to improve awareness of these infections, leading to early identification in clinical settings and increasing research in the field. Improved diagnosis and availability of therapeutic options might contribute to improve the prognosis of patients’ survival. MDPI 2020-11-02 /pmc/articles/PMC7693372/ /pubmed/33147819 http://dx.doi.org/10.3390/antibiotics9110771 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Joao, Ines Bujdáková, Helena Jordao, Luisa Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title | Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title_full | Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title_fullStr | Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title_full_unstemmed | Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title_short | Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients |
title_sort | opportunist coinfections by nontuberculous mycobacteria and fungi in immunocompromised patients |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693372/ https://www.ncbi.nlm.nih.gov/pubmed/33147819 http://dx.doi.org/10.3390/antibiotics9110771 |
work_keys_str_mv | AT joaoines opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients AT bujdakovahelena opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients AT jordaoluisa opportunistcoinfectionsbynontuberculousmycobacteriaandfungiinimmunocompromisedpatients |